The impact of combined iliac occlusive disease and aortic aneurysm on open surgical repair.

Severe aortoiliac occlusive disease is a relative contraindication for endovascular aneurysm repair, owing to an association with high stent graft-related complication and reintervention rates in this population. Open AAA repair requiring aortofemoral bypass (AFB), however, may represent a unique population with differing outcomes from standard open repair. We sought to compare the demographic and procedural characteristics, as well as outcomes of patients undergoing standard intra-abdominal repairs (STD) versus those requiring AFB. Using a prospectively maintained database, we retrospectively identified patients who underwent open AAA repair from 1994 to 2017. A total of 1087 consecutive cases were performed consisting of 981 STD (681 tube graft, 300 aortoiliac) and 106 AFB cases. Demographics, procedural data, postoperative complications, and long-term survival were analyzed. The AFB cohort had more women (39.0 vs 22.8%; P =.001) and higher rates of hypertension (81.1 vs 69.8%; P =.015), chronic obstructive pulmonary disease (28.3 vs 17.4%; P =.006), and smoking (50.9 vs 36%; P =.002). The AFB group had smaller mean aortic (5.22 vs 5.77 cm; P =.001) and graft (17.08 vs 18.2 mm; P =.001) diameters. Proximal clamp position and blood loss were equivalent, although total anesthesia time was longer (295 vs 234 minutes; P =.001) in the AFB cohort. Overall 30-day postoperative morbidity (38.7 vs 24.8%; P =.002) was higher in the AFB group. Specifically, postoperative renal insufficiency (8.2 vs 3.4%; P =.032), wound infection (5.7 vs 1.2%; P =.005), and hematoma/seroma (5.7 vs 1.2%; P =.003) were more likely. Hospital length of stay was longer for AFB (11.9 vs 9.9 days; P =.007). The 30-day mortality (0.9% AFB vs 1.8% STD; P =.50) and major morbidity (17 vs 11.5%; P =.10) did not differ. Reintervention rate within 30 days of the initial surgery (12.3 vs 4.6; P =.001) and overall (33 vs 18.9%; P =.001) was higher in the AFB group. Long-term survival was lower in the AFB group (5-year survival: 63.1% AFB vs 71.9% STD; hazard ratio 0.76, log-rank P =.047). Multivariate regression analysis identified age, comorbid conditions, and aneurysm characteristics—rather than repair type—as independent predictors of 30-day reintervention and mortality at 5 years. Patients requiring AFB for AAA owing to associated iliac occlusive disease have more preoperative comorbidities, postoperative complications, a longer length of stay, reintervention rates and shorter 5-year survival. Patient and aneurysm characteristics rather than surgical repair type appear to be responsible for these differences. Nevertheless, 30-day mortality and major morbidity were comparable, making AFB an attractive alternative to endovascular aneurysm repair in patients with advanced iliac occlusive disease. [ABSTRACT FROM AUTHOR]